Rare Variants in BNC2 Are Implicated in Autosomal-Dominant Congenital Lower Urinary-Tract ObstructionCaroline M. Kolvenbach, Alina C. Hilger, Gabriel C. Dworschak et al.|The American Journal of Human Genetics|2019Cited by 47
The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancersG. Saturno, Caroline J. Springer, Alfonso Zambon et al.|Annals of Oncology|2020Cited by 21